10.63
0.47%
-0.07
OptimizeRx Corp stock is currently priced at $10.63, with a 24-hour trading volume of 33,344.
It has seen a -0.47% decreased in the last 24 hours and a -4.66% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $10.58 pivot point. If it approaches the $10.88 resistance level, significant changes may occur.
Previous Close:
$10.70
Open:
$10.94
24h Volume:
33,344
Market Cap:
$193.66M
Revenue:
$62.81M
Net Income/Loss:
$-13.75M
P/E Ratio:
-12.96
EPS:
-0.82
Net Cash Flow:
$153.00K
1W Performance:
+5.24%
1M Performance:
-4.66%
6M Performance:
+25.44%
1Y Performance:
-26.30%
OptimizeRx Corp Stock (OPRX) Company Profile
Name
OptimizeRx Corp
Sector
Industry
Phone
248-651-6568
Address
400 Water Street, Suite 200, Rochester, MI
OptimizeRx Corp Stock (OPRX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-02-23 | Resumed | B. Riley Securities | Buy |
Nov-01-22 | Initiated | Stifel | Buy |
Jul-15-22 | Initiated | SVB Leerink | Outperform |
Oct-18-21 | Resumed | B. Riley Securities | Buy |
Apr-13-21 | Initiated | RBC Capital Mkts | Outperform |
Jan-03-19 | Initiated | William Blair | Outperform |
View All
OptimizeRx Corp Stock (OPRX) Latest News
Open Text (OTEX) Q3 Earnings Meet Estimates
Zacks Investment Research
OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET
GlobeNewswire Inc.
After Plunging -22.84% in 4 Weeks, Here's Why the Trend Might Reverse for OptimizeRx (OPRX)
Zacks Investment Research
Down -18.75% in 4 Weeks, Here's Why You Should You Buy the Dip in OptimizeRx (OPRX)
Zacks Investment Research
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
GlobeNewswire Inc.
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
GlobeNewswire Inc.
OptimizeRx Corp Stock (OPRX) Financials Data
OptimizeRx Corp (OPRX) Revenue 2024
OPRX reported a revenue (TTM) of $62.81 million for the quarter ending September 30, 2023, a -0.48% decline year-over-year.
OptimizeRx Corp (OPRX) Net Income 2024
OPRX net income (TTM) was -$13.75 million for the quarter ending September 30, 2023, a -31.09% decrease year-over-year.
OptimizeRx Corp (OPRX) Cash Flow 2024
OPRX recorded a free cash flow (TTM) of $153.00 thousand for the quarter ending September 30, 2023, a -97.53% decrease year-over-year.
OptimizeRx Corp (OPRX) Earnings per Share 2024
OPRX earnings per share (TTM) was -$0.80 for the quarter ending September 30, 2023, a -37.93% decline year-over-year.
About OptimizeRx Corp
OptimizeRx Corporation provides digital health messaging to the pharmaceutical industry. The company offers a direct channel for pharmaceutical companies to communicate with healthcare providers. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-Prescribe systems to search, print, or electronically dispense directly to patients, as well as a network of pharmacies; and brand messaging services, such as various brand awareness and clinical messaging services consisting of brand awareness messages, reminder ads, clinical messages, and unbranded messages that could be targeted by specialty, diagnostic code, and other criteria. The company's products and applications also comprise brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing new eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. It has a strategic partnership with Patient Connect to deliver real-time messaging at point-of-care in Europe. OptimizeRx Corporation is based in Rochester, Michigan.
Cap:
|
Volume (24h):